Cardiac Wire #246 February 13, 2025
Novartis Acquires Anthos | COVID’s Heart Risks
Cardiac Wire #245 February 10, 2025
TAVR’s Weekend Effect | SAVR/CABG Advantage
Cardiac Wire #244 February 6, 2025
Lowering Elderly LDL-C | Merck Halts HYPERION
Cardiac Wire #243 February 3, 2025
Increasing CVD Burdens | New Lp(a) Test
Cardiac Wire #242 January 30, 2025
Mechanical AVR Still Matters | Neko’s Full-Body Fundraise
Cardiac Wire #241 January 27, 2025
Abelacimab’s Stroke Uncertainty | Keros Quits TROPOS
Cardiac Wire #240 January 23, 2025
GLP-1 Side Effects | CABG Guideline Debate
Cardiac Wire #239 January 16, 2025
Further Finerenone Findings | Canary’s Potential Obesity Cure
Cardiac Wire #238 January 13, 2025
AI-CCTA Beats SPECT | Coffee’s Heart Benefits
Cardiac Wire #237 January 9, 2025
AI-ECG’s Strong Start | VARIPULSE’s Stroke Scare
Cardiac Wire #236 January 6, 2025
Cardiac Imaging Medicare Scheme | Great Vessels, Great Outcomes
Cardiac Wire #235 December 19, 2024
Challenging CHAGASICS | Merck’s New GLP-1
Cardiac Wire #234 December 16, 2024
Robotic Valve Funding | NHS’ Cardiac Crisis
Cardiac Wire #233 December 12, 2024
Obicetrapib’s Unexpected Outcomes | CV Hospital Costs
Cardiac Wire #232 December 9, 2024
Tirzepatide’s Triumph | Clopidogrel Beats Aspirin
Cardiac Wire #231 December 5, 2024
MariTide’s Weight Loss Milestone | Diabetes’ Early Impact
Cardiac Wire #230 December 2, 2024
Winrevair Wins Again | Boards Are Big Business
Cardiac Wire #229 November 25, 2024
Muvalaplin Aces Lp(a) Test | A New ATTR-CM Option
Cardiac Wire #228 November 21, 2024
